This page contains information about Creatininase ex. Recombinant E.Coli, 500U/ Cas 9025-13-2 and its .
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."